IRulya Therapeutics (IRLA) Operating Leases (2019 - 2026)
IRulya Therapeutics (IRLA) reported Operating Leases of $293,000 for Q1 2026, down 23.5% from $383,000 a year earlier and down 11.2% from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, IRulya Therapeutics posted Operating Leases of $330,000, down 16.2% from FY2024.
- Operating Leases has a five-year compound annual growth rate of 9.7% (FY2020 to FY2025).
- By year, Operating Leases came in at $394,000 in FY2024 (+22.7%), $321,000 in FY2023 and $420,000 in FY2021 (+101.9%).
- The Q1 2026 figure ranks as the lowest quarterly Operating Leases since Q3 2022.
- Year over year, Operating Leases has now declined in each of the last five quarters, with an average decline of 9.1% over the last six quarters.
- The high point for year-over-year Operating Leases in five years was Q3 2021 (growth of 150.0%); the low point was Q3 2022 (a decline of 94.4%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $330,000 (Q4 2025), $359,000 (Q3 2025) and $387,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 293,000.00 |
| Dec 31, 2025 | 330,000.00 |
| Sep 30, 2025 | 359,000.00 |
| Jun 30, 2025 | 387,000.00 |
| Mar 31, 2025 | 383,000.00 |
| Dec 31, 2024 | 394,000.00 |
| Sep 30, 2024 | 450,000.00 |
| Jun 30, 2024 | 453,000.00 |
| Mar 31, 2024 | 394,000.00 |
| Dec 31, 2023 | 321,000.00 |
| Sep 30, 2022 | 34,000.00 |
| Jun 30, 2022 | 95,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Dec 31, 2021 | 420,000.00 |
| Sep 30, 2021 | 610,000.00 |
| Jun 30, 2021 | 773,000.00 |
| Mar 31, 2021 | 171,000.00 |
| Dec 31, 2020 | 208,000.00 |
| Sep 30, 2020 | 244,000.00 |
| Jun 30, 2020 | 50,000.00 |
API Access
IRulya Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();